Completely updated and revised, the 27th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children, including COVID-19. For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens. New in the 27th edition: Continuous updates of drug and dosing changes 4 new chapters Reorganized chapter order to improve functionality
Completely updated and revised, the 28th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens. TOPICS INCLUDE Antimicrobial Therapy by Clinical Syndromes Antimicrobial Therapy for Neonates Choosing Among Antibiotics Antifungal Agents Antiviral Agents Antiparasitic Agents Oral Step-down Therapy for Serious Infections Prevention of Symptomatic Infection Approach to Antibiotic Allergies Antibiotic Stewardship New in the 28th Edition Updated recommendations on acute hematogenous osteomyelitis, based on newly published guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, including information on a decrease in the incidence of MRSA infections, allowing the recommendation of cefazolin, again, in empiric therapy for most pediatric bone infections Updated recommendations on influenza treatment and prophylaxis, reflecting American Academy of Pediatrics guidance for 2021-2022 Ceftazidime/avibactam now preferred over fluoroquinolones for treatment of Klebsiella pneumoniae carbapenemase-producing enteric bacilli, if susceptible Cefiderocol, a new iron-binding siderophore cephalosporin class, recently approved in adults for treatment of many drug-resistant pathogens, particularly Acinetobacter, Stenotrophomonas, and Pseudomonas; under study in children New dosing for posaconazole suspension formulation New approaches to mucormycosis Added baloxavir for children 12+ years old Online updates of COVID-19 therapies once emergency use authorization in children at http://www.aap.org/nelsons Updated Nelson's app also available
Completely updated and revised, the 29th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens. CHAPTERS INCLUDE Antimicrobial Therapy According to Clinical Syndromes Antimicrobial Therapy for Neonates Choosing Among Antibiotics Antifungal Agents Antiviral Agents Antiparasitic Agents Oral Step-down Therapy for Serious Infections Prevention of Symptomatic Infection Approach to Antibiotic Allergies Antibiotic Stewardship Antibiotic Therapy for Children With Obesity
Includes more than 30 new diagnoses and eBook with digital updates as needed! Updated to deliver the most current standards, this is a unique prescribing reference for APRN students and advanced health care providers in all practice settings who need guidance on prescribing drugs for patients with acute, episodic, and chronic health problems. Concise, easy to read, and updated throughout, the resource delivers pharmacotherapy regimens for more than 600 diagnoses—including over 30 that are new. The print format includes an eBook with digital updates to assure immediate access to essential information. Listed alphabetically by diagnosis, pharmacotherapy regimens include, for each diagnosis, drug choices listed by generic name, FDA pregnancy category, generic/over-the-counter availability, adult/pediatric dosing regimens, brand names, forms of dosage, and additives. Clinically useful information such as laboratory values to be monitored, patient teaching points, and safety information is interspersed throughout each diagnosis. Additional quick-access features include information presented in convenient table format and an alphabetical cross-reference index of drugs by generic and brand name, with FDA pregnancy category and controlled drug schedule (I, II, III, IV, V). Key Features: Includes 31 new diagnoses totaling over 600 organized alphabetically Serves as a quick-access prescribing reference for APRN and PA students and health care providers in all primary care settings Presents drug information in condensed and summary form for ease of use Within each diagnosis, drug choices are listed alphabetically by generic /trade name, FDA pregnancy category, adult/pediatric dosing, dose forms, and additives Delivers guidance on lab values to be monitored, patient education points, and safety information Includes 30 Appendices with ready access to key drug classifications, FDA Pregnancy Categories, US Schedule of Controlled Substances, Immunization Schedules, Contraceptive Guidance, categories Anti-Infectives, and more! Offers brand/generic cross-reference
This resource on pediatric antimicrobial therapy provides instant access to reliable, up-to-the-minute recommendations for treatment of all infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens. The program also includes guidelines on when not to prescribe antimicrobials. The book is designed for those who take care of children and are faced with decisions every day.
Designed to suit a wide range of healthcare providers, including primary care, subspecialties, and allied health, Conn’s Current Therapy has been a trusted clinical resource for more than 70 years. The 2020 edition continues this tradition of excellence with current, evidence-based treatment information presented in a concise yet in-depth format. More than 300 topics have been carefully reviewed and updated to bring you state-of-the-art information even in the most rapidly changing areas of medicine. Offers personal approaches from recognized leaders in the field, covering common complaints, acute diseases, and chronic illnesses along with the most current evidence-based clinical management options. Follows a consistent, easy-to-use format throughout, with diagnosis, therapy, drug protocols, and treatment pearls presented in quick-reference boxes and tables for point-of-care answers to common clinical questions. Includes new and significantly revised chapters on neurofibromatosis, autism, psoriatic arthritis, and postpartum depression. Features thorough updates in areas critical to primary care, including Acute Myocardial Infarction • Hypertension • Peripheral Arterial Disease • Valvular Heart Disease • Hepatitis C • Irritable Bowel Syndrome • Obsessive Compulsive Disorder • Chronic Obstructive Pulmonary Disease • Fibromyalgia • Menopause • Travel Medicine • and more. Provides current drug information thoroughly reviewed by PharmDs. Shares the knowledge and expertise of new contributors who provide a fresh perspective in their specialties. Features nearly 300 images, including algorithms, anatomical illustrations, and photographs, that provide useful information for diagnosis.
Completely updated and revised, the 30th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens. Free updates are available at aap.org/Nelsons. New in the 30th Edition Updated multiple drug-resistant gram-negative pathogens treatment recommendations with newly approved antibiotics Newer antibiotics, beyond vancomycin, to treat MRSA infections Updates on children's influenza, COVID-19, and enterovirus treatments Updates on travelers' diarrhea Latest guidelines for treatment of invasive pediatric fungal infections New guidelines for treatment of pediatric bacterial arthritis Recommendations on hepatitis C virus and cytomegalovirus treatment options CHAPTERS INCLUDE Antimicrobial Therapy According to Clinical Syndromes Antimicrobial Therapy for Neonates Choosing Among Antibiotics Antifungal Agents Antiviral Agents Antiparasitic Agents Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens; Fungal Pathogens; Viral Pathogens; and Parasitic Pathogens Approach to Antibiotic Therapy for Drug-Resistant Gram-Negative Bacilli and Methicillin-Resistant Staphylococcus aureus Systemic and Topical Antimicrobial Dosing and Dose Forms Sequential Parenteral-Oral Antibiotic Therapy (Oral Step-Down Therapy) for Serious Infections Antimicrobial Prophylaxis/Prevention of Symptomatic Infection Approach to Antibiotic Allergies Antibiotic Stewardship Antibiotic Therapy for Children With Obesity And more...
The book provides a comprehensive and up-to-date overview of pediatric ENT infections. It brings together the experience of authors from more than 30 countries and aims to provide a broader understanding of the prevention and treatment of infectious diseases in children, that will likely lead to improve their health globally. In addition to new infections like COVID-19, the work reviews the latest treatments modalities. The list of topics ranges from basic to very advanced and the book will be therefore an invaluable resource for ENT and pediatrics trainees and students, as well as for experienced practitioners in these fields.
An unrivaled reference tool for advanced practice providers and students in clinical practice settings This concise and easy-to-read drug therapy prescribing reference provides critical information for advanced practice nurses and physician assistants in clinical practice settings who are involved in the primary care management of patients with acute, episodic, and chronic health problems, life-altering and life-threatening diseases, and needs for health promotion and disease prevention. Interspersed with clinically useful information, such as monitored laboratory values, patient teaching points, and safety information, this reference draws upon data taken directly from FDA-approved drug labels and patient medication guides, and is organized by diagnosis rather than by drug classification, to provide advanced practice practitioners with the comprehensive, concise, and up-to-date information on drug therapies that they need to help achieve positive outcomes in their daily practice. The first section of this book presents drug treatment regimens for over 700 clinical diagnoses, listed alphabetically by generic name, followed by important information required for prescription decision-making. The second section provides additional information on treatment, organized in a convenient table format. An alphabetical cross-reference index of drugs allows for easy identification of alternate drug names and their location within the text. New to this Edition: Information on over 100 new diagnoses and over 100 new generic drugs indicated for the treatment of quality of life-altering and life-threatening conditions such as chronic kidney disease, genetic diseases, mesothelioma, MS, metastatic cancers, and rare diseases. Updates on drugs used for site-specific cancers, mental health issues, and commonly diagnosed diseases such as diabetes and asthma. Details on new drug approvals including indications, treatment regimens, adverse reactions, drug-drug interactions, warnings and precautions, and use in special populations Key Features: Provides new drug treatment regimens for drugs that are first in class, novel drugs, orphan drugs, new drugs with breakthrough or fast track designation and drugs with new indications and expanded social populations. Includes drug prescribing information on diseases prevalent outside of North America, including endemic diseases with known transmission and treatment interventions. Serves advanced practice providers across the United States and internationally. Consistent with approvals and recommendations for use by the FDA.
The new edition of this highly successful annual pocket guide presents clinicians with the most recent information in the field of antimicrobial therapy and infectious diseases. Written by recognised experts in infectious disease, this edition discusses serum and urinary spectrum summaries of antibiotics and clinically relevant pharmacokinetics. The seventeenth edition has been fully updated to provide clinicians with the latest advances in their field. Unique features of the book include clinical synopses of common and uncommon infections worldwide, differential diagnosis of infectious diseases and non-infectious mimics, antibiotic IV-to-PO switch therapy options for infectious diseases; and HIV, HCV, Peds ID, antibiotic prophylaxis and immunisations, chest film differential diagnosis atlas, and gram stain atlas. Key Points Seventeenth edition presenting most recent information in field of antimicrobial therapy and infectious disease Highly successful annual pocket guide Includes many new topics and updates on new drugs Authored by leading experts in the field Includes free access to the app
